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SUMMARY
The feasibility of a rubella screening and vaccination programme for unvaccinated young women
was assessed after the 2004/2005 epidemic in The Netherlands. All 640 young women in two
villages with low vaccination coverage were invited for a rubella seroprevalence test. Information
on vaccination status was gathered by written questionnaire. Women testing seronegative were
oﬀered free rubella vaccination. The feasibility of the programme was evaluated in terms of
participation, rubella susceptibility, and acceptance of the vaccination oﬀer by seronegative
women. The participation rate was 48% [95% conﬁdence interval (CI) 44–52] with 108
unvaccinated participants. Eleven per cent (95% CI 6–19) of the women were identiﬁed as
susceptible to rubella, of whom 17% (95% CI 2–48) accepted the vaccination oﬀer. In the end
only 0.9% (95% CI 0.1–2.5) of the target population was given protection by the programme.
Under the present conditions this programme proved to be an ineﬃcient strategy for rubella
protection.
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Rubella is generally a mild infectious disease.
However, during pregnancy it may cause serious
congenital malformations in the foetus known as
congenital rubella syndrome (CRS). Rubella and CRS
can be prevented by vaccination [1] and in The
Netherlands rubella vaccination was introduced for
girls only as part of a national vaccination programme
in 1974. In 1987, this was replaced by the two-dose
measles-mumps-rubella (MMR) vaccination for all
children. Despite vaccination coverage of >95%, a
rubella epidemic occurred in 2004/2005 and similar to
rubella outbreaks among the Amish in the USA [2],
this epidemic was largely conﬁned to an orthodox
Protestant minority group that refrains from vacci-
nation for religious reasons [3].
To prevent CRS, all young women should be pro-
tected against rubella either via vaccination or the
acquisition of a natural immunity prior to child-
bearing age. During the 2004/2005 epidemic, the
Dutch municipal health services oﬀered free MMR
vaccination to unvaccinated children and adolescents.
However, the acceptance of this was very limited.
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Similarly, a personal recall for missed vaccinations to
unvaccinated 16-year-olds (as registered in the Prov-
incial Vaccination Register) also showed only 7%
vaccination acceptance [4].
In contrast to the low vaccination acceptance rates,
the unvaccinated rubella patients and their parents
proved very willing to undergo diagnostic procedures
to conﬁrm rubella infection during the epidemic de-
spite the results having no therapeutic consequences
for them. Given the interest of unvaccinated girls and
their parents in the serostatus of the girls, it was
decided to develop a screening programme to detect
rubella susceptibility among unvaccinated young
women, oﬀer MMR vaccination to those found to be
seronegative, and thereby increase protection against
rubella. This strategy has been suggested by others [5],
and the objective of the present study was therefore to
test the feasibility of such a strategy.
All 640 women aged 14–20 years from two villages
with large unvaccinated orthodox Protestant popu-
lations were invited to take part in the study. Overall
MMR vaccination coverage in these villages was 63%
for the birth cohorts invited for the study. The target
group of the programme was unvaccinated young
women but to avoid stigmatization, the serological
test was oﬀered to all young women, irrespective of
vaccination status.
Invitations for the serological test and ques-
tionnaires accompanied by an informed consent form
were mailed to all of the women in the study popu-
lation. For girls aged <18 years, the parents were
approached and asked to provide written consent.
Vaccination status was assessed retrospectively via
the questionnaire. Women who did not know their
vaccination status were assumed to be unvaccinated.
Blood samples were taken in the villages by nurses
from the municipal health service.To foster partici-
pation, the blood samples were collected via ﬁnger
prick, which has been shown to allow suﬃciently
sensitive serological testing relative to testing of serum
collected via venepuncture [6, 7]. Blood obtained via
ﬁnger prick was spotted on ﬁlter paper and dried. The
blood specimen was reconstituted in the laboratory
and tested for the presence of rubella-speciﬁc
IgG antibodies (Enzygnost1, Dade Behring GmbH,
Germany). Rubella IgG test results <4 IU/ml were
classiﬁed as negative; test results o15 IU/ml were
classiﬁed as protective; test results between 4 and
14 IU/ml were classiﬁed as equivocal. Women with
initially equivocal test results were asked to provide a
second blood sample but now via venous puncture.
These blood samples were again tested for rubella IgG
using another test (AxSYM1, Abbott Diagnostics,
USA) due to the diﬀerent logistics associated with the
collection of the diﬀerent blood samples. Venous blood
test resultso15 IU/ml were considered protective.
All of the participants received personal written
feedback regarding the laboratory results. Unprotec-
ted women were oﬀered MMR vaccination free of
charge.
Only the analyses of the data from the subgroup of
previously unvaccinated participants are presented
here. Discussion of waning immunity among the sub-
group of vaccinated women is beyond the scope of this
report. The data were analysed using SPSS software,
version 13 (SPSS Inc. USA). Percentages were calcu-
lated for participation, rubella susceptibility, and ac-
ceptance of vaccination. The diﬀerent subgroups of
participants classiﬁed according to religious denomi-
nation, age, and education were compared using
Fisher’s exact tests.
The participation in our study was 48% (95% CI
44–52). A total of 307 women participated in the study
of whom 108 (35%, 95% CI 30–41) belonged to the
target group of unvaccinated women. The character-
istics of the participants are presented in Table 1.
Vaccination status was signiﬁcantly related to re-
ligious denomination. The majority of the unvacci-
nated women (77 women, 71%) belonged to orthodox
Protestant denominations. Vaccination status was not
associated with age or educational level.
Table 1. Characteristics of respondents
n %
Age (years)
14–17 205 66.8
18–20 102 33.2
Total 307 100.0
Education
Low 205 67.0
High 101 33.0
Total 306 100.0
Religion
Orthodox Protestant 87 28.8
Other religions 140 46.4
No religion 75 24.8
Total 302 100.0
Vaccination status
Vaccinated 199 64.8
Not vaccinated 91 29.6
Unknown by respondent 17 5.5
Total 307 100.0
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Eleven per cent (95% CI 6–19) of the unvaccinated
women were susceptible to rubella. The results of the
serological testing of the ﬁnger prick blood from 108
unvaccinated women showed ﬁve (5%) to be sero-
negative, 10 (9%) to have equivocal results and 93
(86%) to be protected against rubella. After venous
blood testing for those with initially equivocal results,
three more women could be considered protected as
their venous rubella IgG was o15 IU/l ; ﬁve women
were unprotected, and two women did not return for
repeated testing and were therefore also considered
unprotected. Therefore, 12 (11%, 95% CI 6–19)
unvaccinated women were considered susceptible to
rubella. Rubella susceptibility in the unvaccinated
women was clearly associated with religious denomi-
nation. A higher percentage of the women belonging
to orthodox Protestant religious denominations were
protected against rubella when compared to the
women belonging to other religious denominations
or women with no religious denomination (Table 2).
In addition, a higher percentage of the younger un-
vaccinated women (i.e. those aged 14–17 years) were
protected against rubella when compared to the older
group (i.e. those aged 18–20 years). Rubella suscep-
tibility in unvaccinated women was not associated
with educational level.
Only 17% (2/12, 95% CI 2–48) of rubella-
susceptible, formerly unvaccinated women agreed to
subsequent MMR vaccination by the municipal
health service. Both women did not belong to an
orthodox Protestant denomination.
These outcomes were used to assess the feasibility
of the screening and vaccination programme. The
eﬃciency of the programme is dependent on the
participation rate of the target group, their rubella
susceptibility and the acceptance of vaccination by
those susceptible. Thus it can be concluded that
0.48r0.11r0.17r100=0.9% (95% CI 0.1–2.5) of
the target group of unvaccinated young women was
provided protection by the programme. In other
words: the invitation to 100 unvaccinated young
women for rubella screening will lead to acceptance of
a vaccination oﬀer by only 1 susceptible woman. Ten
women will remain susceptible because they do not
agree to screening (0.52r0.11r100=6 women) or
refuse vaccination after testing seronegative (0.48r
0.11r0.83r100=4 women). Eighty-nine out of 100
unvaccinated women are already protected by nat-
urally acquired immunity.
Our results show that rubella screening of un-
vaccinated women prior to childbearing age, followed
by the oﬀer of MMR vaccination to those who tested
seronegative has only a very limited eﬀect on rubella
protection in an area with low vaccination coverage
due to religious objections.
The participation rate in our study was 48%. As
the vaccination coverage found for our study popu-
lation is consistent with the historical vaccination
coverage, it could be assumed that the participation
rate for the target group of unvaccinated young
women was independent of their vaccination status
and equal to the overall participation rate. Moreover,
the participation rate found in the present study is
comparable to the participation rate of 52.5% found
in a 1996 population-based immunosurvey of low
vaccine coverage municipalities in The Netherlands
[8]. The necessity of parental consent for girls aged
<18 years did not aﬀect participation. The partici-
pation rate for the younger groupwas even higher than
the participation rate for the older group. The aim of
the screening and vaccination programme is to prevent
rubella in pregnancy; therefore, the fact that for most
women aged between 14 and 20 years, pregnancy is
not yet an issue may contribute to the relatively low
participation rates we found. Preconception rubella
screening and vaccination may thus result in higher
participation rates and has recently been rec-
ommended by the Dutch Health Council [9].
Rubella susceptibility among unvaccinated young
women was found to be only 11%, which reﬂects the
high likelihood of naturually acquiring the rubella
infection in these villages. Before the 2004/2005 epi-
demic there must also have been circulation of rubella
virus in The Netherlands, as rubella seroprevalence in
areas with low vaccination coverage in the 1996
population-based serosurvey for the same generation
Table 2. Rubella susceptibility of unvaccinated
women according to religion and age (n=108)
Percentage
susceptible (n)
Percentage
protected (n)
Total 11% (12) 89% (96)
According to religion*#
Orthodox protestant 4% (3) 96% (74)
Other or no religion 31% (9) 69% (20)
According to age$
14–17 years 4% (3) 96% (67)
18–20 years 24% (9) 76% (29)
* Information on religious denomination was missing for
two respondents.
# Fisher’s exact test : P<0.001.
$ Fisher’s exact test : P=0.004.
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of unvaccinated youth – who were then aged 5–10
years – was already about 65% [10]. The higher sero-
prevalence in unvaccinated orthodox Protestant
women relative to other groups of unvaccinated
women is consistent with the observation that most
cases in the 2004/2005 epidemic were found to occur in
groups who refrained from vaccination for religious
reasons [3]. Similarly, the ﬁnding that the 14- to
17-year-old unvaccinated women were better pro-
tected against rubella than the 18- to 20-year-old
womenmay reﬂect the fact that the younger age group
had a higher probability of exposure during attend-
ance at secondary school (often an orthodox Prot-
estant school) than the older age group, which no
longer attended school.
The acceptance of the vaccination oﬀer by the pre-
viously unvaccinated seronegative women was lim-
ited. However, we were unable to assess the acceptance
of the oﬀer with much precision due to the small
number of women identiﬁed as susceptible. Neverthe-
less, the reasons for low vaccination acceptance may
be similar to the reasons mentioned for low partici-
pation. Religious objections may also give rise to a
conﬂict of conscience on the part of unprotected
youngwomen in particular.Moreover, as pregnancy is
not as yet an issue, the decision to accept vaccination
can also be postponed. Therefore, it is possible that a
vaccination oﬀer following preconceptional screening
will result in higher rates of vaccination acceptance.
Applying the Wilson–Jungner criteria for mass
screening adopted by the WHO in 1968, we conclude
that there is a serious health problem, a suitable test
and an appropriate ‘ treatment ’ (i.e. vaccination).
However, at the observed levels of participation,
rubella susceptibility and vaccination acceptance, the
screening of unvaccinated women prior to child bear-
ing age is most probably not a cost-eﬀective strategy
in The Netherlands and therefore not recommended.
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